Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
MRUS
$94.81
-0.09%
Analyze
1M
+37.6%
3M
+41.9%
1Y
+78.7%
Market Cap:
$7.17B
Merus BV
Healthcare |
Biotechnology
Merus NV, a clinical-stage immuno-oncology company, is dedicated to the discovery and development of bispecific antibody therapies in the Netherlands. The company is headquartered in Utrecht, the Netherlands.
Click "Analyze" to generate stock analysis
MRUS Price Trend and Signals
MRUS Option Volumes & Open Interests (aggregated)
MRUS Put Call Ratios and IV (aggregated)
MRUS Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-16
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-15
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-13
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-09
Somewhat Bullish
price_signal
Yearly high detected.